Observational × Myeloproliferative Disorders × Other hematologic neoplasm × Clear all Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms
Active not recruiting
100 enrolled
CHIS
Not yet recruiting
5,000 enrolled
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Recruiting
30 enrolled
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active not recruiting
153 enrolled
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
Recruiting
5,000 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
EpiC
Recruiting
120 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
Completed
100 enrolled
Myeloproliferative Neoplasms (MPNs) Patient Registry
Recruiting
5,000 enrolled
eTHEMA
Recruiting
3,000 enrolled
HemaTMA
Active not recruiting
5,000 enrolled
SARS-CoV-2 Donor-Recipient Immunity Transfer
Completed
26 enrolled
MPL - NPM
Unknown
30 enrolled
(ANSWer)
Completed
119 enrolled
BUFLU
Completed
143 enrolled
Collecting and Storing Blood Samples From Patients With Cancer
Withdrawn
PREDICARE
Completed
420 enrolled
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Terminated
150 enrolled
Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes
Completed
726 enrolled
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
Unknown
1,000 enrolled
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Completed
304 enrolled
Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
Completed
36 enrolled
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
Completed
459 enrolled
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
Terminated
9 enrolled
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Completed
41 enrolled
Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders
Withdrawn
B-Receptor Signaling in Cardiomyopathy
Completed
99 enrolled
Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
Withdrawn
S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
Completed
1,294 enrolled
S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
Completed
3,341 enrolled
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Terminated
24 enrolled
Investigation of the Cylex® ImmuKnow® Assay
Completed
45 enrolled
Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer
Terminated
48 enrolled
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
Withdrawn
Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
Terminated
252 enrolled
Studying Fentanyl in Patients With Cancer
Terminated
2 enrolled
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
Completed
190 enrolled
Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation
Completed
168 enrolled
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
Terminated
60 enrolled